Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-CO2 pseudogene 32 (MTCO2P32) is a non-protein-coding pseudogene in the human genome, annotated on the nuclear chromosome and not on the mitochondrial genome[3][7]. It is homologous to the MT-CO2 gene, which encodes cytochrome c oxidase II (a subunit of mitochondrial respiratory complex IV)[1][9], but as a pseudogene, MTCO2P32 contains sequence similarity to the protein-coding gene but does not produce a functional enzyme or play a direct role in mitochondrial electron transport or other cellular processes[3][7]. There is no evidence that this pseudogene is a receptor, enzyme, transporter, or other therapeutic target, nor has it been associated with any direct disease function, drug interaction, or clinical biomarker role[3][7][5][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-CO2 pseudogene 32 (MTCO2P32).